APA (7th ed.) Citation

Fangchao, Z., Feng, D., Haolin, L., Xue, W., Jian, Y., & Peng, Y. (2022). Recent Progress of Palbociclib in Treatment of HR+/HER2- Breast Cancer. Zhongliu Fangzhi Yanjiu, 49(7), 703-708. https://doi.org/10.3971/j.issn.1000-8578.2022.22.0220

Chicago Style (17th ed.) Citation

Fangchao, ZHENG, DU Feng, LIU Haolin, WANG Xue, YUE Jian, and YUAN Peng. "Recent Progress of Palbociclib in Treatment of HR+/HER2- Breast Cancer." Zhongliu Fangzhi Yanjiu 49, no. 7 (2022): 703-708. https://doi.org/10.3971/j.issn.1000-8578.2022.22.0220.

MLA (9th ed.) Citation

Fangchao, ZHENG, et al. "Recent Progress of Palbociclib in Treatment of HR+/HER2- Breast Cancer." Zhongliu Fangzhi Yanjiu, vol. 49, no. 7, 2022, pp. 703-708, https://doi.org/10.3971/j.issn.1000-8578.2022.22.0220.